BIDMC scientists discover vulnerability that offers new strategy to combat triple-negative breast cancer


Posted in: Medical Science News | Medical Research News | Women’s Health News

Tags: Arthritis, Breast Cancer, Cancer, Cancer Treatment, Cell, Chemotherapy, Diabetes, DNA, Doxorubicin, Drugs, Estrogen, Hair Loss, Healthcare, Hospital, in vitro, in vivo, Laboratory, Medical School, Nausea, Pathology, Progesterone, Rheumatoid Arthritis, Tumor